Eventide Asset Management – SYNDAX PHARMACEUTICALS

Eventide Asset Management ownership history of SYNDAX PHARMACEUTICALS
QuarterValueSharesWeighting
Q1 2021$45,100
4.2%
2,016,993
3.6%
0.67%
0.6%
Q4 2020$43,279
319.4%
1,946,000
178.3%
0.66%
228.7%
Q3 2020$10,320
41.4%
699,200
42.0%
0.20%
27.0%
Q2 2020$7,299
193.5%
492,500
117.3%
0.16%
96.3%
Q1 2020$2,487
-5.5%
226,680
0.7%
0.08%
-45.6%
Q3 2017$2,633
-16.2%
225,0000.0%0.15%
-24.0%
Q2 2017$3,143225,0000.20%